Wednesday, July 8, 2026

pharma · Hepatocellular Carcinoma · Obesity

Hospital Authority

Hospital Authority trial registry — 323 ClinicalTrials.gov studies with program phase, status, and indication context.

Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN HQ
1991 Founded
12,669 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN
Founded
1991
Employees
12,669
Programs
322
Drugs
301
Patents
0
Intelligence · Clinical Trials

Hospital Authority clinical trials

Registry index of 323 ClinicalTrials.gov studies linked to Hospital Authority programs — each row shows trial ID, program name, phase, status, and indication.

Hospital Authority trial registry — 323 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Hospital Authority.

  1. TCHIRB-970208-E — Phase 3

    Clinical update
  2. Remimazolam_OPCAB — Unknown

    Clinical update
  3. Art-BTC — Phase 2

    Clinical update
  4. 201010025M — Approved

    Clinical update
  5. SNUCPT08_GCPGC — Phase 1

    Clinical update
  6. DAC-HAAG-02 — Phase 3

    Clinical update
  7. FEMH-95011 — Phase 2

    Clinical update
  8. Warfarin Sodium — Phase 3

    Clinical update

Trial registry

323 studies